[1]
2026. A Review on the Therapeutic Targeting of the Gut Microbiome for the Mitigation of Type 2 Diabetes Mellitus: Review article. Journal of Pharma Insights and Research. 4, 3 (Jun. 2026), 099–116. DOI:https://doi.org/10.69613/7rzc7r52.